Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort

Y. Huang (Ann Arbor, United States of America), K. Opron (Ann Arbor, United States of America), J. Erb-Downward (Ann Arbor, United States of America), L. Begley (Ann Arbor, United States of America), N. Alexis (Chapel Hill, United States of America), I. Barjaktarevic (Los Angeles, United States of America), G. Barr (New York , United States of America), E. Bleecker (Tucson, United States of America), R. Bowler (Denver, United States of America), S. Christenson (San Francisco, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), D. Couper (Chapel Hill, United States of America), C. Doerschuk (Chapel Hill, United States of America), M. Dransfield (Birmingham, United States of America), M. Han (Ann Arbor, United States of America), A. Hastie (Winston-Salem, United States of America), E. Hoffman (Iowa City, United States of America), R. Kaner (New York, United States of America), J. Krishnan (Chicago, United States of America), W. O'Neal (Chapel Hill, United States of America), R. Paine 3rd (Salt Lake City, United States of America), S. Peters (Winston-Salem, United States of America), M. Wells (Birmingham, United States of America), P. Woodruff (San Francisco, United States of America), F. Martinez (New York, United States of America), J. Curtis (Ann Arbor, United States of America), G. Huffnagle (Ann Arbor, United States of America)

Source: International Congress 2019 – Basic research of airway diseases
Session: Basic research of airway diseases
Session type: Oral Presentation
Number: 3580

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Huang (Ann Arbor, United States of America), K. Opron (Ann Arbor, United States of America), J. Erb-Downward (Ann Arbor, United States of America), L. Begley (Ann Arbor, United States of America), N. Alexis (Chapel Hill, United States of America), I. Barjaktarevic (Los Angeles, United States of America), G. Barr (New York , United States of America), E. Bleecker (Tucson, United States of America), R. Bowler (Denver, United States of America), S. Christenson (San Francisco, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), D. Couper (Chapel Hill, United States of America), C. Doerschuk (Chapel Hill, United States of America), M. Dransfield (Birmingham, United States of America), M. Han (Ann Arbor, United States of America), A. Hastie (Winston-Salem, United States of America), E. Hoffman (Iowa City, United States of America), R. Kaner (New York, United States of America), J. Krishnan (Chicago, United States of America), W. O'Neal (Chapel Hill, United States of America), R. Paine 3rd (Salt Lake City, United States of America), S. Peters (Winston-Salem, United States of America), M. Wells (Birmingham, United States of America), P. Woodruff (San Francisco, United States of America), F. Martinez (New York, United States of America), J. Curtis (Ann Arbor, United States of America), G. Huffnagle (Ann Arbor, United States of America). Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. 3580

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: